The prevalence of heart failure (HF) continues to escalate and currently affects over 6.5 million Americans. Despite advances in medical and device therapy, significant residual risk remains for morbidity and mortality. What can nurse practitioners (NPs) do to change this? How can NPs best navigate new developments and decide which therapies to implement with their own patients?
This session addresses 10 pivotal issues in the management of HF, while providing guidance for clinicians in areas where evidence is insufficient to inform decision making. Further, practical strategies will be presented so that by the end of this session, NPs will leave with greater confidence and knowledge to pursue the latest treatment options for their patients.
Sample